Transseptal puncture for the treatment of structural heart disease: conventional needle or radiofrequency needle?

Courtesy of Dr. José Álvarez.

Transseptal Puncture for the Treatment of Structural Heart Disease: Conventional Needle or Radiofrequency Needle?This study sought to find differences in the transseptal puncture technique between the use of a conventional needle and the use of a radiofrequency-powered needle.

 

A total of 52 patients who underwent transseptal puncture for the treatment of various types of heart disease (Mitraclip, Watchman, Lariat, and mitral valvuloplasty) were retrospectively analyzed. A conventional needle was used in 25 cases (BRK, St Jude Medical) and a radiofrequency needle was used in the other 27 (Baylis Medical, Canada). All procedures included a transesophageal echocardiography; intended and actual puncture sites were analyzed in orthogonal views.

 

As a result, the puncture was effective in all cases in which a radiofrequency needle was used. As regards the conventional needle group, three patients required the use of an assistance wire to cross the septum and two patients had to be crossed over to the radiofrequency group. There were no differences as regards accuracy in the puncture site, but the time to septum crossing was lower for patients in the radiofrequency group. Septum tenting was higher in patients in the conventional needle group.

 

Editorial Comment

This is a retrospective observational study comparing two transseptal puncture techniques. Results were similar, except for a lower degree of septum tenting with a radiofrequency needle, which can be beneficial in cases in which the septum is lax and the conventional technique entails a risk of lesion to the left atrial lateral wall.

 

Courtesy of Dr. José Álvarez.

 

Original title: Accuracy and procedural characteristics of standard needle compared with radiofrequency needle transseptal puncture for structural heart interventions.

Authors: Gaufav Sharma MD, Gagan D Singh MD. Thomas Smith MD. Dali Fan MD, Reginald Low MD, Jason Rogers MD.

Reference: Cathet Cardiovasc Interv 2017; 89(6):E200-E206.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...